Who is this study for: Patients with COVID-19 Post-Infectious Autoimmune Disease
Enrollment Status: Recruiting
Publish Date: May 26, 2021
Intervention Type: Combination Product
Study Drugs: PurWetFurFatPurApoPurPhlPurCloPurInfSmoliv
Study Phase: Phase 1/Phase 2
Summary: Post-acute sequelae of SARS-CoV-2 infection can cause multiple system function disorders, and complicated symptoms last for an extended period. The virus can cause this continued infection, or the virus causes immune system function disorder and post-infectious autoimmune disease. The clinical symptoms can be smell loss, taste loss to liver function disorder, kidney function failure, different. No...